Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06931405 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised at 47 of 47 sites
    v13
  2. Study sites: 46 to 47v12
  3. Study sites: 44 to 46v11
  4. Study sites: 39 to 44v10
  5. Study sites: 37 to 39v9
Show 7 earlier versionsHide 7 earlier versions
  1. Study sites: 32 to 37
    • Eligibility criteria shortened, about 6 words
    v8
  2. Study sites: 26 to 32v7
  3. Study sites: 15 to 26v6
  4. Study sites: 11 to 15v5
  5. Study sites: 9 to 11v4
  6. Study sites: 6 to 9v3
  7. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 6
    • Primary and study completion dates: Dec 2026 to Dec 31, 2026
    • Start date changed from estimate of May 1, 2025 to May 28, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT inhibitor, in participants with CIndU (Part A) or CSU (Part B).
Trial Details
NCT Number NCT06931405
Lead Sponsor Blueprint Medicines Corporation
Conditions
(from sponsor)		 Chronic Inducible Urticaria, Chronic Spontaneous Urticaria
Related terms Chronic Inducible Urticaria, Chronic Urticaria, Cold Urticaria, Familial dermographism
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov